Galapagos NV ADR (GLPG)

Schlusskurs vom Vortag:

$28.45

Offen:

$28.3

24-Stunden-Volumen:

149.91K

Marktkapitalisierung:

$1.93B

Einnahmen:

$261.10M

Nettoeinkommen (Verlust:

$228.29M

KGV:

-12.52

EPS:

-2.3434

Netto-Cashflow:

$-460.37M

1W Leistung:

+1.98%

1M Leistung:

-9.67%

6M Leistung:

-11.97%

1J Leistung:

-26.48%

1-Tages-Spanne:

$28.30

$29.44

52-Wochen-Spanne:

$28.30

$45.21

Galapagos NV ADR Stock (GLPG) Company Profile

Firmenname

Galapagos NV ADR

Sektor

Healthcare (1189)

Branche

Biotechnology (685)

Telefon

32 1 534 29 00

Adresse

Generaal De Wittelaan L11 A3, Mechelen

Mitarbeiter

712

Twitter

@GalapagosGlobal

Nächster Verdiensttermin

2024-05-02

Neueste SEC-Einreichungen

GLPG's Discussions on Twitter

Galapagos NV ADR Stock (GLPG) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-08-24	Herabstufung	Citigroup	Buy → Neutral
2023-05-05	Hochstufung	Raymond James	Mkt Perform → Outperform
2023-01-23	Hochstufung	Jefferies	Underperform → Hold
2022-11-07	Herabstufung	Raymond James	Outperform → Mkt Perform
2022-09-09	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2022-01-27	Hochstufung	Citigroup	Neutral → Buy
2021-08-19	Herabstufung	Barclays	Overweight → Equal Weight
2021-08-06	Herabstufung	Deutsche Bank	Buy → Hold
2021-04-20	Eingeleitet	Deutsche Bank	Buy
2021-04-14	Hochstufung	Barclays	Equal Weight → Overweight
2021-02-23	Hochstufung	BofA Securities	Underperform → Neutral
2021-02-19	Hochstufung	Raymond James	Mkt Perform → Outperform
2021-02-11	Herabstufung	Citigroup	Buy → Neutral
2021-01-19	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-11-19	Eingeleitet	Maxim Group	Buy
2020-10-21	Herabstufung	Goldman	Neutral → Sell
2020-08-25	Herabstufung	Jefferies	Buy → Hold
2020-08-24	Herabstufung	H.C. Wainwright	Buy → Neutral
2020-08-19	Herabstufung	Barclays	Overweight → Equal Weight
2020-08-19	Hochstufung	Citigroup	Neutral → Buy
2020-07-10	Herabstufung	Stifel	Buy → Hold
2020-03-30	Hochstufung	Jefferies	Hold → Buy
2020-03-18	Hochstufung	RBC Capital Mkts	Underperform → Sector Perform
2020-02-25	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2020-02-24	Herabstufung	BofA/Merrill	Neutral → Underperform
2020-02-20	Herabstufung	RBC Capital Mkts	Sector Perform → Underperform
2020-01-06	Herabstufung	JP Morgan	Overweight → Neutral
2019-12-18	Herabstufung	Citigroup	Buy → Neutral
2019-12-17	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2019-12-13	Herabstufung	Credit Suisse	Outperform → Neutral
2019-12-02	Eingeleitet	BofA/Merrill	Neutral
2019-09-09	Fortgesetzt	Morgan Stanley	Overweight
2019-07-31	Hochstufung	UBS	Neutral → Buy
2019-07-29	Herabstufung	Jefferies	Buy → Hold

Alle ansehen

Galapagos NV ADR Aktie (GLPG) Neueste Nachrichten

Galapagos’ aandeelhouders keuren alle door de Raad van Bestuur voorgestelde besluiten goed op de jaarlijkse Gewone en Buitengewone Algemene Aandeelhoudersvergaderingen 2024

GlobeNewswire Inc.

Down -9.97% in 4 Weeks, Here's Why You Should You Buy the Dip in Galapagos (GLPG)

Zacks Investment Research

Bristol Myers (BMY) Reports Positive Colorectal Cancer Study Data

Zacks Investment Research

Fate Therapeutics (FATE) Surges 86.4% YTD on Pipeline Progress

Zacks Investment Research

Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024

GlobeNewswire Inc.

Amylyx (AMLX) Withdraws ALS Drug, Cuts Workforce by 70%

Zacks Investment Research

Finanzdaten der Galapagos NV ADR-Aktie (GLPG)

Galapagos NV ADR (GLPG) Umsatz 2024

Galapagos NV ADR (GLPG) Nettogewinn 2024

Galapagos NV ADR (GLPG) Free Cashflow 2024

Galapagos NV ADR (GLPG) Gewinn je Aktie 2024